dc.contributor.author
Brachs, Sebastian
dc.contributor.author
Winkel, Angelika F.
dc.contributor.author
Tang, Hui
dc.contributor.author
Birkenfeld, Andreas L.
dc.contributor.author
Brunner, Bodo
dc.contributor.author
Jahn-Hofmann, Kerstin
dc.contributor.author
Margerie, Daniel
dc.contributor.author
Ruetten, Hartmut
dc.contributor.author
Schmoll, Dieter
dc.contributor.author
Spranger, Joachim
dc.date.accessioned
2018-06-08T10:36:06Z
dc.date.available
2017-01-09T09:29:09.559Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/20721
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-24020
dc.description.abstract
Objective Non-alcoholic fatty liver disease is a world-wide health concern and
risk factor for cardio-metabolic diseases. Citrate uptake modifies
intracellular hepatic energy metabolism and is controlled by the conserved
sodium-dicarboxylate cotransporter solute carrier family 13 member 5 (SLC13A5,
mammalian homolog of INDY: mINDY). In Drosophila melanogaster and
Caenorhabditis elegans INDY reduction decreased whole-body lipid accumulation.
Genetic deletion of Slc13a5 in mice protected from diet-induced adiposity and
insulin resistance. We hypothesized that inducible hepatic mINDY inhibition
should prevent the development of fatty liver and hepatic insulin resistance.
Methods Adult C57BL/6J mice were fed a Western diet (60% kcal from fat, 21%
kcal from carbohydrate) ad libitum. Knockdown of mINDY was induced by weekly
injection of a chemically modified, liver-selective siRNA for 8 weeks. Mice
were metabolically characterized and the effect of mINDY suppression on
glucose tolerance as well as insulin sensitivity was assessed with an ipGTT
and a hyperinsulinemic-euglycemic clamp. Hepatic lipid accumulation was
determined by biochemical measurements and histochemistry. Results Within the
8 week intervention, hepatic mINDY expression was suppressed by a liver-
selective siRNA by over 60%. mINDY knockdown improved hepatic insulin
sensitivity (i.e. insulin-induced suppression of endogenous glucose
production) of C57BL/6J mice in the hyperinsulinemic-euglycemic clamp.
Moreover, the siRNA-mediated mINDY inhibition prevented neutral lipid storage
and triglyceride accumulation in the liver, while we found no effect on body
weight. Conclusions We show that inducible mINDY inhibition improved hepatic
insulin sensitivity and prevented diet-induced non-alcoholic fatty liver
disease in adult C57BL6/J mice. These effects did not depend on changes of
body weight or body composition.
en
dc.rights.uri
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject
Insulin resistance
dc.subject
Citrate transport
dc.subject
Lipid accumulation
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit
dc.title
Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic
insulin sensitivity and prevents diet-induced non-alcoholic fatty liver
disease in mice
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation
Molecular Metabolism. - 5 (2016), 11, S. 1072-1082
dcterms.bibliographicCitation.doi
10.1016/j.molmet.2016.08.004
dcterms.bibliographicCitation.url
http://dx.doi.org/10.1016/j.molmet.2016.08.004
refubium.affiliation
Charité - Universitätsmedizin Berlin
de
refubium.mycore.fudocsId
FUDOCS_document_000000026098
refubium.resourceType.isindependentpub
no
refubium.mycore.derivateId
FUDOCS_derivate_000000007486
dcterms.accessRights.openaire
open access